
Outset Medical, Inc.: shareholders and insiders
Price
$3.16
November 17, 2026Market cap $58M
What Ploutos Investor adds for Outset Medical
Part of Ploutos Investor, €9.99 a month
- The full history: 8 fiscal years, from 2018
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 29% since Nov 4, 2026, when the 10-Q these figures come from was filed ($4.44 then, $3.16 on Nov 17, 2026). The figures date from before that move.10-Q
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
Insiders and their shares
Purchases and sales by officers and directors from Nov 18, 2025 to Nov 17, 2026, from their own Form 4 filings.
Bought on the market
$870.3K
1 person
Sold on the market
$391.0K
5 people
From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 18, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $870.3K by 1 person·sold $384.3K by 4 people
- 2025: no buys, sold $6.8K by 1 person
- 2026: bought $870.3K by 1 person, sold $384.3K by 4 people
- Nov 16, 2026Renee GaetaChief Financial OfficerKind
- Nov 16, 2026Leslie TriggChair and CEOKind
- Oct 2, 2026Braden Michael LeonardKind
- Oct 1, 2026Braden Michael LeonardKind
- Aug 17, 2026Leslie TriggChair and CEOKind
- Aug 17, 2026John L. BrottemGeneral CounselKind
- Aug 17, 2026Renee GaetaChief Financial OfficerKind
- Jun 26, 2026John L. BrottemGeneral CounselKind
- Jun 26, 2026Renee GaetaChief Financial OfficerKind
- Jun 26, 2026Leslie TriggChair and CEOKind
- Jun 4, 2026Patrick T HackettDirectorKind
- Jun 4, 2026Kevin C OboyleDirectorKind
- Jun 4, 2026Karen PrangeDirectorKind
- Jun 4, 2026Brent D. LangDirectorKind
- Jun 4, 2026D Keith GrossmanDirectorKind
- Jun 4, 2026Karen DrexlerDirectorKind
- Jun 3, 2026Renee GaetaChief Financial OfficerKind
- May 15, 2026John L. BrottemGeneral CounselKind
- May 15, 2026Marc NashEVP Operations R&D & ServiceKind
- May 15, 2026Leslie TriggChair and CEOKind
- Feb 17, 2026Leslie TriggChair and CEOKind
- Feb 17, 2026John L. BrottemGeneral CounselKind
- Feb 17, 2026Marc NashEVP Operations R&D & ServiceKind
- Jan 21, 2026Leslie TriggChair and CEOKind
- Jan 21, 2026John L. BrottemGeneral CounselKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Renee GaetaChief Financial Officer | 4,498 | $3.67 | $16.5K | Form 4 | |
| Nov 16, 2026 | Leslie TriggChair and CEO | 3,403 | $3.67 | $12.5K | Form 4 | |
| Oct 2, 2026 | Braden Michael Leonard | 16.6K | $3.88 | $64.2K | Form 4 | |
| Oct 1, 2026 | Braden Michael Leonard | 228.3K | $3.53 | $806.0K | Form 4 | |
| Aug 17, 2026 | Leslie TriggChair and CEO | 3,437 | $4.39 | $15.1K | Form 4 | |
| Aug 17, 2026 | John L. BrottemGeneral Counsel | 2,632 | $4.39 | $11.6K | Form 4 | |
| Aug 17, 2026 | Renee GaetaChief Financial Officer | 4,543 | $4.39 | $19.9K | Form 4 | |
| Jun 26, 2026 | John L. BrottemGeneral Counsel | 59.8K | – | – | Form 4 | |
| Jun 26, 2026 | Renee GaetaChief Financial Officer | 71.6K | – | – | Form 4 | |
| Jun 26, 2026 | Leslie TriggChair and CEO | 99.2K | – | – | Form 4 | |
| Jun 4, 2026 | Patrick T HackettDirector | 10.7K | – | – | Form 4 | |
| Jun 4, 2026 | Kevin C OboyleDirector | 10.7K | – | – | Form 4 | |
| Jun 4, 2026 | Karen PrangeDirector | 10.7K | – | – | Form 4 | |
| Jun 4, 2026 | Brent D. LangDirector | 10.7K | – | – | Form 4 | |
| Jun 4, 2026 | D Keith GrossmanDirector | 10.7K | – | – | Form 4 | |
| Jun 4, 2026 | Karen DrexlerDirector | 10.7K | – | – | Form 4 | |
| Jun 3, 2026 | Renee GaetaChief Financial Officer | 17.7K | $4.94 | $87.3K | Form 4 | |
| May 15, 2026 | John L. BrottemGeneral Counsel | 2,638 | $3.70 | $9.8K | Form 4 | |
| May 15, 2026 | Marc NashEVP Operations R&D & Service | 1,582 | $3.70 | $5.9K | Form 4 | |
| May 15, 2026 | Leslie TriggChair and CEO | 3,445 | $3.70 | $12.7K | Form 4 | |
| Feb 17, 2026 | Leslie TriggChair and CEO | 3,361 | $3.35 | $11.3K | Form 4 | |
| Feb 17, 2026 | John L. BrottemGeneral Counsel | 2,842 | $3.35 | $9.5K | Form 4 | |
| Feb 17, 2026 | Marc NashEVP Operations R&D & Service | 1,817 | $3.35 | $6.1K | Form 4 | |
| Jan 21, 2026 | Leslie TriggChair and CEO | 2,120 | $5.05 | $10.7K | Form 4 | |
| Jan 21, 2026 | John L. BrottemGeneral Counsel | 1,180 | $5.01 | $5.9K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 5, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by OM's officers and directors from 2020 up to November 17, 2025, 6 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 1 more, back to 2020
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- BML Investment Partners, L.P.Share of class14.7%
- FMRwith 1 more personShare of class14.5%
- Perceptive Advisors LLCwith 3 more personsShare of class6.70%
- AQR Capital Management, LLCwith 1 more personShare of class5.39%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| BML Investment Partners, L.P. | 14.7% | 2.76M | Oct 6, 20265 filings since Jan 14, 2026 | 13G/A | |
| FMRwith 1 more person | 14.5% | 2.60M | Apr 7, 20252 filings since Feb 12, 2025 | 13G/A | |
| Perceptive Advisors LLCwith 3 more persons | 6.70% | 1.21M | May 15, 20252 filings since Feb 28, 2025 | 13G/A | |
| AQR Capital Management, LLCwith 1 more person | 5.39% | 999.0K | Aug 12, 2026 | 13G |
Fell to 5% or less (8)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- Bank of America3.50%Aug 12, 202613G/A
- BlackRock, Inc.2.00%Jul 29, 202613G/A
- Woodline Partners LP1.60%May 15, 202613G/A
- Alyeska Investment Group, L.P.0.00%May 15, 202613G/A
- The Vanguard Group0.00%Mar 27, 202613G/A
- Durable Capital Partners LP0.00%Feb 17, 202613G/A
- PFM Health Sciences, LP2.90%Feb 17, 202613G/A
- T. Rowe Price Investment Management, Inc.0.00%Nov 14, 202513G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Citadel Advisors (Griffin)In the quarter
- Millennium Mgmt (Englander)In the quarter
- Renaissance TechnologiesIn the quarter+40%
- AQR CapitalIn the quarter+24%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Citadel Advisors (Griffin) | 11.2K | $0 | 0.00% | |
| Millennium Mgmt (Englander) | 181.8K | $800.0K | 0.00% | |
| Renaissance Technologies | 60.6K | +40% | $200.0K | 0.00% |
| AQR Capital | 999.0K | +24% | $4.3M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 5.09% of its shares outstanding were held short, +17.6% since the report before.
- Shares held short
- 932.6K
- 5.09%
- Since the report before792.7K on Sep 30, 2026
- +17.6%
- 3.8
- 246.1K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 46%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 8.42M
- Nov 15, 2023: Shares held short 7.99M
- Nov 30, 2023: Shares held short 7.70M
- Dec 15, 2023: Shares held short 7.61M
- Dec 29, 2023: Shares held short 7.32M
- Jan 12, 2024: Shares held short 8.14M
- Jan 31, 2024: Shares held short 8.32M
- Feb 15, 2024: Shares held short 8.02M
- Feb 29, 2024: Shares held short 8.09M
- Mar 15, 2024: Shares held short 8.52M
- Mar 28, 2024: Shares held short 8.36M
- Apr 15, 2024: Shares held short 8.58M
- Apr 30, 2024: Shares held short 9.45M
- May 15, 2024: Shares held short 9.03M
- May 31, 2024: Shares held short 8.71M
- Jun 14, 2024: Shares held short 8.71M
- Jun 28, 2024: Shares held short 8.56M
- Jul 15, 2024: Shares held short 7.59M
- Jul 31, 2024: Shares held short 7.10M
- Aug 15, 2024: Shares held short 3.66M
- Aug 30, 2024: Shares held short 3.90M
- Sep 13, 2024: Shares held short 4.39M
- Sep 30, 2024: Shares held short 3.47M
- Oct 15, 2024: Shares held short 3.47M
- Oct 31, 2024: Shares held short 3.35M
- Nov 15, 2024: Shares held short 2.90M
- Nov 29, 2024: Shares held short 2.80M
- Dec 13, 2024: Shares held short 2.62M
- Dec 31, 2024: Shares held short 2.46M
- Jan 15, 2025: Shares held short 6.46M
- Jan 31, 2025: Shares held short 9.08M
- Feb 14, 2025: Shares held short 10.01M
- Feb 28, 2025: Shares held short 11.23M
- Mar 14, 2025: Shares held short 11.82M
- Mar 31, 2025: Shares held short 876.8K
- Apr 15, 2025: Shares held short 1.02M
- Apr 30, 2025: Shares held short 1.12M
- May 15, 2025: Shares held short 561.8K
- May 30, 2025: Shares held short 564.6K
- Jun 13, 2025: Shares held short 1.01M
- Jun 30, 2025: Shares held short 2.29M
- Jul 15, 2025: Shares held short 2.19M
- Jul 31, 2025: Shares held short 2.16M
- Aug 15, 2025: Shares held short 2.19M
- Aug 29, 2025: Shares held short 1.95M
- Sep 15, 2025: Shares held short 1.85M
- Sep 30, 2025: Shares held short 1.72M
- Oct 15, 2025: Shares held short 1.95M
- Oct 31, 2025: Shares held short 1.73M
- Nov 14, 2025: Shares held short 2.10M
- Nov 28, 2025: Shares held short 2.12M
- Dec 15, 2025: Shares held short 2.22M
- Dec 31, 2025: Shares held short 2.33M
- Jan 15, 2026: Shares held short 2.29M
- Jan 30, 2026: Shares held short 2.27M
- Feb 13, 2026: Shares held short 2.22M
- Feb 27, 2026: Shares held short 1.92M
- Mar 13, 2026: Shares held short 2.09M
- Mar 31, 2026: Shares held short 1.95M
- Apr 15, 2026: Shares held short 2.09M
- Apr 30, 2026: Shares held short 2.01M
- May 15, 2026: Shares held short 2.05M
- May 29, 2026: Shares held short 2.22M
- Jun 15, 2026: Shares held short 1.97M
- Jun 30, 2026: Shares held short 1.49M
- Jul 15, 2026: Shares held short 1.22M
- Jul 31, 2026: Shares held short 1.14M
- Aug 14, 2026: Shares held short 936.3K
- Aug 31, 2026: Shares held short 901.7K
- Sep 15, 2026: Shares held short 889.6K
- Sep 30, 2026: Shares held short 792.7K
- Oct 15, 2026: Shares held short 932.6K
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading39.5% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 39.5% of the shares in the reported trades were short sales, against 47.9% in the 14 before.
- Last 14 sessionsOct 29, 2026 – Nov 17, 2026
- 39.5%
- The 14 beforeOct 9, 2026 – Oct 28, 2026
- 47.9%
- Change
- -8.4 pts
- Short sales a dayon average, of 52.5K shares
- 20.8K
- More than atof 3,666 US-listed companies, same days
- 18%
- Median of alleight in ten from 34.6% to 63.7%
- 50.3%
- Short sales
- Oct 9, 2026: Short sales 40.6%
- Oct 12, 2026: Short sales 42.4%
- Oct 13, 2026: Short sales 55.4%
- Oct 14, 2026: Short sales 54.9%
- Oct 15, 2026: Short sales 64.3%
- Oct 16, 2026: Short sales 53.2%
- Oct 19, 2026: Short sales 48.4%
- Oct 20, 2026: Short sales 54.1%
- Oct 21, 2026: Short sales 59%
- Oct 22, 2026: Short sales 60.4%
- Oct 23, 2026: Short sales 38.8%
- Oct 26, 2026: Short sales 29.8%
- Oct 27, 2026: Short sales 20.1%
- Oct 28, 2026: Short sales 18.6%
- Oct 29, 2026: Short sales 16.7%
- Oct 30, 2026: Short sales 40%
- Nov 2, 2026: Short sales 41.1%
- Nov 3, 2026: Short sales 32.4%
- Nov 4, 2026: Short sales 23.8%
- Nov 5, 2026: Short sales 49.5%
- Nov 6, 2026: Short sales 29.5%
- Nov 9, 2026: Short sales 20%
- Nov 10, 2026: Short sales 40.9%
- Nov 11, 2026: Short sales 20.7%
- Nov 12, 2026: Short sales 56.5%
- Nov 13, 2026: Short sales 50.5%
- Nov 16, 2026: Short sales 49.9%
- Nov 17, 2026: Short sales 62.1%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Braden Michael LeonardDirectly2.76M
- Steven S. WilliamsonChief Commercial OfficerDirectly320.3K
- Jean-Olivier RacineChief Technology OfficerDirectly265.3K
- Leslie TriggChair and CEODirectly233.4K
- Patrick T HackettDirectorDirectly230.8K
- Renee GaetaChief Financial OfficerDirectly176.3K
- John L. BrottemGeneral CounselDirectly87.5K
- Stacey L. PorterChief People OfficerDirectly61.4K
- Brent D. LangDirectorDirectly45.2K
- Marc NashEVP Operations R&D & ServiceDirectly38.4K
- D Keith GrossmanDirectorDirectly37.4K
- Kevin C OboyleDirectorDirectly34.8K
- Karen PrangeDirectorDirectly29.3K
- Karen DrexlerDirectorDirectly23.4K
- Nabeel AhmedChief Financial OfficerDirectly16.1K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Braden Michael Leonard | 2.76M | – | Oct 2, 2026 | Form 4 |
| Steven S. WilliamsonChief Commercial Officer | 320.3K | – | Feb 15, 2024 | Form 4 |
| Jean-Olivier RacineChief Technology Officer | 265.3K | – | May 10, 2024 | Form 4 |
| Leslie TriggChair and CEO | 233.4K | – | Nov 16, 2026 | Form 4 |
| Patrick T HackettDirector | 230.8K | – | Jun 4, 2026 | Form 4 |
| Renee GaetaChief Financial Officer | 176.3K | – | Nov 16, 2026 | Form 4 |
| John L. BrottemGeneral Counsel | 87.5K | – | Aug 17, 2026 | Form 4 |
| Stacey L. PorterChief People Officer | 61.4K | – | Jan 16, 2024 | Form 4 |
| Brent D. LangDirector | 45.2K | – | Jun 4, 2026 | Form 4 |
| Marc NashEVP Operations R&D & Service | 38.4K | – | May 15, 2026 | Form 4 |
| D Keith GrossmanDirector | 37.4K | – | Jun 4, 2026 | Form 4 |
| Kevin C OboyleDirector | 34.8K | – | Jun 4, 2026 | Form 4 |
| Karen PrangeDirector | 29.3K | – | Jun 4, 2026 | Form 4 |
| Karen DrexlerDirector | 23.4K | – | Jun 4, 2026 | Form 4 |
| Nabeel AhmedChief Financial Officer | 16.1K | – | May 15, 2025 | Form 4 |
A lower bound: it counts only the 15 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.02%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.00%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- ITOTiShares Core S&P Total U.S. Stock Market ETFWeight in the fund0.00%
- DFACDimensional U.S. Core Equity 2 ETFWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
6 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 101
- Q4 2025: Managers 100
- Q1 2026: Managers 99
- Q2 2026: Managers 93
Institutional investors by quarter
The fund managers holding OM, quarter by quarter, from Q3 2020 to Q2 2025, 20 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 93 managers held 14.19M shares, worth $61M. During the quarter 20 opened a position, 23 closed one, 30 added and 27 trimmed.
The largest holders, Q2 2026
- FMRIn the quarter
- BML Capital ManagementIn the quarter+32%
- AQR CapitalIn the quarter+24%
- Perceptive AdvisorsIn the quarter
- Vanguard Capital ManagementIn the quarter+2.1%
- Assenagon Asset ManagementIn the quarter+35%
- Bank of AmericaIn the quarter-30%
- PFM Health SciencesIn the quarter-2.1%
- Ensign Peak AdvisorsIn the quarter-18%
- BlackRockIn the quarter-67%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| FMR | 2.74M | $12M | |
| BML Capital Management | 2.52M | +32% | $11M |
| AQR Capital | 999.0K | +24% | $4.3M |
| Perceptive Advisors | 833.3K | $3.6M | |
| Vanguard Capital Management | 780.1K | +2.1% | $3.4M |
| Assenagon Asset Management | 678.9K | +35% | $2.9M |
| Bank of America | 665.8K | -30% | $2.9M |
| PFM Health Sciences | 582.1K | -2.1% | $2.5M |
| Ensign Peak Advisors | 434.3K | -18% | $1.9M |
| BlackRock | 418.2K | -67% | $1.8M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Outset Medical's filings show?
Who buys and sells is one part of Outset Medical's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have OM's insiders bought or sold?
From Jun 5, 2026 to Nov 17, 2026 Outset Medical's insiders bought $870.3K and sold $162.9K of shares on the market. 0% of the sales were under set 10b5-1 plans.
Which well-known managers hold OM?
4 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $4.3M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.